A new test that measures RNA or protein molecules in human cells can accurately identify viral infection as a cause of respiratory symptoms, according to a Yale study published Dec. 21 in The Journal of Infectious Diseases. Performed with a simple nasal...
The National Clinician Scholars Program (NCSP) at Yale is pleased to announce the selection of seven new scholars who will be joining Yale School of Medicine in July 2018.
The NCSP is an inter-professional fellowship program designed to prepare a select...
Aging impairs the immune system’s response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death from flu, the researchers said...
A small-molecule inhibitor tested by researchers at Yale and Stanford may be the answer to blocking the spread of harmful mosquito-borne pathogens, including Zika and dengue viruses, according to a new study published in Cell Reports.
The molecule, dubbed...
In a new study, Yale researchers describe the role of a protein that promotes growth of melanoma, the deadliest form of skin cancer.
The gene, MELK, encodes a protein kinase — an enzyme that modifies other proteins — and is over-expressed in melanoma...
Thyroid hormone therapy significantly resolves fibrosis, or scarring, in the lungs of mice, increasing their survival from disease, a Yale-led study shows. This provides a novel insight into the development of pulmonary fibrosis and could lead to...
In a study led by researchers at Yale and The Jackson Laboratory, investigators zeroed in on a specific cell type that is uniquely responsible for activating a strong response to vaccination. The insight could lead to changes in how vaccines are developed...
Hepatitis C infection is a global phenomenon that affects millions worldwide, with an estimated 30,500 new cases in the United States alone each year. Expanding treatment, however, could go a long way toward preventing transmission of the virus among high...
HIV is more common among individuals in the criminal justice system than among people in the community, but just a fraction of people with HIV in prison or jail receive prompt care after release, say Yale researchers. In a new study published in The...
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this problem by targeting a wider...